The effect of oral ondansetron in the prevention of postoperative nausea and vomiting after major gynaecological surgery performed under general anaesthesia
- 1 March 1993
- journal article
- clinical trial
- Published by Wiley in Anaesthesia
- Vol. 48 (3) , 214-218
- https://doi.org/10.1111/j.1365-2044.1993.tb06904.x
Abstract
The efficacy and safety of ondansetron in preventing postoperative nausea and vomiting following major gynaecological surgery was evaluated in this multicentre, double‐blind study. A total of 243 patients were randomised to receive three doses of oral ondansetron 8 mg or matching placebo at 8‐hourly intervals, with the first dose being given an hour before surgery. A standard general anaesthetic technique was employed throughout. Nausea, vomiting and safety assessments were performed continuously during the 24 h postrecovery period. Of the 237 patients evaluated for efficacy, significantly fewer ondansetron 8 mg treated patients (65/117: 56%) experienced postoperative nausea and/or vomiting compared with placebo‐treated patients (94/120; 78%) during the study period (p < 0.001). In addition, ondansetron 8 mg reduced the severity of nausea (p < 0.001) and the total number of vomiting episodes experienced (p < 0.001). Overall, ondansetron 8 mg was well tolerated and effective in preventing postoperative nausea and vomiting in this surgical setting. Copyright © 1993, Wiley Blackwell. All rights reservedSCOPUS: ar.jFLWINinfo:eu-repo/semantics/publisheKeywords
This publication has 15 references indexed in Scilit:
- Antiemetic Efficacy of Ondansetron After Outpatient LaparoscopyAnesthesia & Analgesia, 1991
- Treatment of Postoperative Nausea and Vomiting With OndansetronAnesthesia & Analgesia, 1991
- Prevention of Postoperative Nausea and Vomiting Using Ondansetron, a New, Selective, 5-HT3 Receptor AntagonistAnesthesia & Analgesia, 1991
- DwarfsAnesthesiology, 1990
- A739 ONDANSETRON, A SELECTIVE SEROTONIN TYPE 3 (5-HT3) ANTAGONIST, REDUCES NAUSEA AND VOMITING IN FEMALES FOLLOWING MAJOR GYNECOLOGIC SURGERYAnesthesiology, 1990
- A36 Ondansetron Decreases Emetic Symptoms Following Outpatient LaparoscopyAnesthesiology, 1990
- Consensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrainTrends in Pharmacological Sciences, 1990
- The efficacy of GR38032F, an Antagonist of 5-hydroxytryptamine-3 (5-HT3) in the prophylaxis of cisplatin (CDDP)-induced nausea and vomitingEuropean Journal of Cancer and Clinical Oncology, 1988
- PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONISTThe Lancet, 1987
- CPPB During Surgical AnesthesiaAnesthesia & Analgesia, 1974